KRAS and adenoma: We investigated the expression amounts of cell cycle, and differentiation markers among Tyr::CreERT2; BrafCA/+ adenomas, Tyr::CreERT2; BrafCA//+;Lkb1flox/+ adenocarcinomas and Kras+/LSLG12Vgeo adenomas and adenocarcinomas.